Mary Kenneally

Müllerian Inhibiting Substance Inhibits Breast Cancer Cell Growth through an NFκB-mediated Pathway

Dorry L. Segev, Thanh U. Ha, Trinh T. Tran et al. · Journal of Biological Chemistry · 2000 · 135 citations · Full text

Cancer Research, Breast Oncology, Mis Action +14

Human ovarian cancer, cell lines, and primary ascites cells express the human Mullerian inhibiting substance (MIS) type II receptor, bind, and are responsive to MIS.

Peter T. Masiakos, David T. MacLaughlin, Shyamala Maheswaran et al. · PubMed · 1999 · 122 citations

Flow Cytometry, Type Ii Receptor, Oncogenic Agent +13

Human Müllerian inhibiting substance: Enhanced purification imparts biochemical stability and restores antiproliferative effects

Richard C. Ragin, Patricia K. Donahoe, Mary Kenneally et al. · Protein Expression and Purification · 1992 · 66 citations

Restores Antiproliferative Effects, Biochemistry, Experimental Therapeutic +3

Mullerian duct regression and antiproliferative bioactivities of mullerian inhibiting substance reside in its carboxy-terminal domain.

David T. MacLaughlin, Peter Hudson, Ana Lía Graciano et al. · Endocrinology · 1992 · 65 citations

Molecular Pharmacology, Signal Transduction, Isolated Dimer +15

ATP synthase complex from bovine heart mitochondria. Passive H+ conduction through F0 does not require oligomycin sensitivity-conferring protein.

Michael J. Pringle, Mary Kenneally, Saroj Joshi · Journal of Biological Chemistry · 1990 · 18 citations · Full text

Molecular Biology, Mitochondrial Biology, Chemical Biology +21